Hexarelin 5mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Hexarelin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF122025097

Key analytical results include:

• Assay Content: 5.41 mg
• Identification – Retention Time: 0.995
• Identification – Spectrum: 994
• Purity: 99.7 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Hexarelin is a synthetic peptide research compound frequently studied in controlled laboratory environments investigating endocrine signalling and peptide–receptor interaction pathways.

The compound belongs to a class of growth hormone secretagogue peptides that interact with specific receptor systems involved in hormonal signalling and regulatory feedback loops.

This preparation contains 5 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves molecular stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Due to its well-characterised peptide structure and stable analytical profile, Hexarelin has become a commonly referenced compound in experimental models studying peptide receptor activity and endocrine signalling mechanisms.

Compound Overview

Hexarelin is a synthetic hexapeptide belonging to the growth hormone secretagogue family of research peptides.

Within biochemical research settings, the compound is frequently investigated for its interaction with the growth hormone secretagogue receptor (GHS-R), a receptor involved in hormonal signalling pathways.

Laboratory models involving Hexarelin often focus on receptor-mediated signalling processes and endocrine regulatory mechanisms.

These studies allow researchers to explore peptide–receptor dynamics, intracellular signalling cascades and hormonal regulatory networks.

Historical Background and Scientific Context

Scientific interest in peptide-based signalling compounds expanded significantly during the late twentieth century as advances in peptide synthesis and molecular biology enabled detailed study of hormone signalling pathways.

During the 1990s researchers began investigating growth hormone secretagogue peptides and their interaction with newly identified receptor systems involved in endocrine signalling.

Hexarelin emerged as one of the synthetic peptides used in laboratory models studying peptide-mediated receptor activation and hormonal regulatory mechanisms.

Since that time the compound has remained a reference molecule in experimental research examining peptide signalling pathways and endocrine regulatory networks.

Mechanistic Focus in Research

Within experimental laboratory environments, Hexarelin is frequently studied in relation to receptor-mediated peptide signalling and endocrine regulatory pathways.

Research investigations commonly explore:

• Growth hormone secretagogue receptor interaction
• Peptide–receptor signalling dynamics
• Endocrine regulatory pathway modelling
• Hormonal feedback signalling systems
• Intracellular signal transduction pathways
• Comparative peptide signalling research
• Experimental endocrine network analysis

These models allow researchers to investigate complex biochemical signalling mechanisms involved in hormonal regulation and peptide receptor activation.

Research Applications

In controlled research environments, Hexarelin may be utilised in experimental models designed to explore endocrine signalling systems and peptide receptor interactions.

Examples of research applications include:

• Peptide receptor interaction studies
• Hormonal signalling pathway investigation
• Endocrine regulatory system modelling
• Comparative peptide compound evaluation
• Cell signalling pathway analysis
• Intracellular regulatory network research
• Controlled in vitro peptide signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 5.41 mg
Confirmed purity 99.7 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.